Rising global expenditure
Spending on innovative treatments is rising thanks to substantial government incentives and public advocacy for innovative treatments.
Diversification benefits
Offers diversification benefits alongside a healthcare portfolio.
Attractive companies
Biotech companies are innovation-led, high-growth, defensive commercial businesses.
Supported by long-term trends
Ageing global population is feeding demand for chronic disease management and treatment of
age-related conditions.
Why invest in biotechnology?
Biotechnology companies are revolutionising treatment paradigms across therapeutic areas, offering strong growth opportunities for investors. Advancements in human genetics have accelerated drug development, providing a deeper understanding of disease mechanisms, allowing new target identification, and enabling more precise and effective therapies. The continuing global focus on healthcare needs and the potential for high returns could make biotechnology an attractive addition to a diversified investment portfolio.
Hover to learn more